Mesenchymal stem cells decrease lung inflammation during sepsis, acting through inhibition of the MAPK pathway

Abstract

This study demonstrated that MSCs are able to inhibit the MAPK pathway activation, modulating the inflammatory response during sepsis. This understanding that MSCs can remodel the response of host cells and improve the course of sepsis is essential for developing new treatments for this pathology.